Literature DB >> 19392799

MHC class I chain-related gene A transmembrane polymorphism in Spanish women with breast cancer.

R Lavado-Valenzuela1, M Benavides, F Carabantes, A Alonso, A Caballero.   

Abstract

The NKG2D-major histocompatibility complex class I-related chain A (MICA) system plays a key role in the antitumoral immune response. We studied five alleles of a microsatellite in the MICA transmembrane region; one of which (MICA-A5.1) gives rise to a truncated protein. The MICA-A5 allele was reduced in breast cancer patients compared with healthy controls (P = 0.04). Given the association between the HLA-B7 allele and the susceptibility to breast cancer in our area, we also analyzed the distribution of the frequency of the MICA alleles in human leukocyte antigen (HLA)-B7 patients compared with patients with the other alleles. The MICA-A5.1 allele was increased in HLA-B7 patients (P = 0.0003). These results suggest that the MICA-A5 allele appears to confer protection against human breast cancer and that the MICA-A5.1 appears to increase the susceptibility to breast cancer in HLA-B7 patients in our area.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19392799     DOI: 10.1111/j.1399-0039.2009.01254.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

1.  MICA polymorphisms and cancer risk: a meta-analysis.

Authors:  Mengyao Ji; Jun Wang; Lei Yuan; Yunting Zhang; Jixiang Zhang; Weiguo Dong; Xiulan Peng
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Correlation of major histocompatibility complex class I related A (MICA) polymorphism with the risk of developing breast cancer.

Authors:  Sadeq Vallian; Morteza Javadi Rad; Mahmood Tavallaei; Manoochehr Tavassoli
Journal:  Med Oncol       Date:  2011-01-08       Impact factor: 3.064

3.  Clinical implication of HLA class I expression in breast cancer.

Authors:  Koichi Kaneko; Sumiya Ishigami; Yuko Kijima; Yawara Funasako; Munetsugu Hirata; Hiroshi Okumura; Hiroyuki Shinchi; Chihaya Koriyama; Shinichi Ueno; Heiji Yoshinaka; Shoji Natsugoe
Journal:  BMC Cancer       Date:  2011-10-20       Impact factor: 4.430

4.  A variant upstream of HLA-DRB1 and multiple variants in MICA influence susceptibility to cervical cancer in a Swedish population.

Authors:  Dan Chen; Joanna Hammer; David Lindquist; Annika Idahl; Ulf Gyllensten
Journal:  Cancer Med       Date:  2014-01-07       Impact factor: 4.452

5.  Interaction Between Polymorphisms of IFN-γ and MICA Correlated with Hepatocellular Carcinoma.

Authors:  Hongguang Li; Fangfeng Liu; Huaqiang Zhu; Xu Zhou; Jun Lu; Hong Chang; Jinhua Hu
Journal:  Med Sci Monit       Date:  2016-02-19

6.  Single nucleotide polymorphism of rs2596542 and the risk of hepatocellular carcinoma development: A meta-analysis.

Authors:  Xue-Jun Kuang; Dun-Chang Mo; Yan Qin; Bhavesh K Ahir; Jian-Jun Wang; Zhao Peng; Zu-Liang Deng
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

7.  The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA.

Authors:  Antje Isernhagen; Daniela Schilling; Sebastian Monecke; Pranali Shah; Leslie Elsner; Lutz Walter; Gabriele Multhoff; Ralf Dressel
Journal:  Immunogenetics       Date:  2015-11-19       Impact factor: 2.846

Review 8.  The Biological Influence and Clinical Relevance of Polymorphism Within the NKG2D Ligands.

Authors:  Jianmin Zuo; Fiyaz Mohammed; Paul Moss
Journal:  Front Immunol       Date:  2018-08-16       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.